SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (536)4/27/1999 11:45:00 PM
From: Gunter RICHTER  Read Replies (1) of 4474
 
Finally a statement worth 5 cents. Ariad , as a stock play is dead. The company does not have the internal science -to- marketable product infrastructure nor the prowess to raise or manage its cash reserves( for a finance expert, their financial underbelly is a horror story) Ariad as we know it could not bring anything to market. Some of its work will be picked up, combined with other findings and a real pharmaceutical company will eventually bring out a usable product. A Mickey Mouse boutique lab, even with talented scientists toiling away, will not rise up to be a pharmaceutical company over night. The Ariad story is over.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News